2025 Partners
MS Bioworks
Expertise Partner
MS Bioworks is a specialized contract research organization focused on mass spectrometry-based proteomics. We provide high-quality proteomics services, including protein identification, quantitation, and biomarker discovery, serving pharmaceutical, biotech, and academic clients. With advanced mass spectrometry platforms and a team of skilled scientists, MS Bioworks delivers reliable data for applications in drug development, biomarker discovery and validation, and disease research, supporting clients in achieving high standards of protein analysis
SYNCELL
Expertise Partner
SYNCELL is a life science technology company at the forefront of developing tools for next-generation proteomics. Our pioneering Microscoop® technology enables the discovery of spatial protein constituents, making de novo subcellular spatial proteomics feasible for the first time. This groundbreaking technology can be applied to a broad range of biological problems, aiding in the understanding of molecular mechanisms, identifying novel disease biomarkers, and revealing new drug targets.
BIOGNOSYS
Innovation Partner
At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that transform science for better lives. With our versatile portfolio of next generation proteomics solutions, including the TrueDiscovery®, TrueTarget®, and TrueSignature® research service platforms, our flagship software Spectronaut®, and the PQ500™ kit, we make the proteome actionable to empower research, drug development, and clinical decision-making. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Our unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins with industry-leading precision, depth, and throughput. Through our strategic partnership with Bruker (Nasdaq: BRKR), we make proteomics globally accessible.
OmicScouts
Innovation Partner
OmicScouts facilitates next generation drug discovery with its expertise in chemical proteomics. We provide services integrating quantitative mass-spectrometry and bioinformatics with biochemical and cell culture expertise. Our technologies enable comprehensive drug target deconvolution, mode of action analyses and biomarker discovery. Founded by leading proteomics researchers, the company has a track record collaborating with top pharmaceutical and biotechnology companies.
BigOmics Analytics
Exhibition Partner
BigOmics Analytics is a Swiss-based company that expedites tertiary proteomics, RNA-Seq and metabolomics data analysis, by providing a data discovery platform for scientists to efficiently scale their data analysis and obtain reproducible results. Through its collaborative analysis platform, Omics Playground, researchers can interactively share data and insights, fostering efficient collaboration. For more information, visit www.bigomics.ch
Nomic
Event Partner
At Nomic, we are making protein profiling broadly accessible. At the heart of our platform is the nELISA™, a proprietary technology that enables massive multiplexing with true flexibility, full quantification, and unmatched cost-efficiency. Nomic has developed the most comprehensive solution for inflammation research that allows for the high-throughput quantification of hundreds of secreted proteins. Nomic is rapidly expanding its biological footprint to cover proteins across the entire proteome, unlocking new possibilities for diverse applications, uses cases, and disease areas.
Pelago Bioscience
Event Partner
Pelago Bioscience supports drug discovery teams with our patented CETSA® (Cellular Thermal Shift Assay) technology, delivering biologically relevant insights directly from natural cell environments. As the pioneers of CETSA, we provide fast, actionable data to minimize risks, prioritize compounds, and drive progress. With services tailored to your goals, we’re more than a CRO—we’re your dedicated partner in advancing your drug discovery journey with confidence and precision.